PNC Financial Services Group
ALNA

PNC Financial Services Group’s Allena Pharmaceuticals ALNA Stock Holding History

PNC Financial Services Group’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,000
Closed -$6K – 4795
2021
Q4 		$6K Buy
+10,000
New +$7.82K ﹤0.01% 3952

Other funds holding ALNA

TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PNC Financial Services Group's ALNA Position: Q1 2022 in Review

PNC Financial Services Group sold out of Allena Pharmaceuticals (ALNA) in Q1 2022, closing a stake of 10,000 shares — an estimated $6K sold.

PNC Financial Services Group first reported a position in ALNA in Q4 2021 and held it in 1 quarter. The position peaked at $6K in Q4 2021. 28 funds tracked by Wall St. Rank hold ALNA as of Q1 2022.

  • PNC Financial Services Group reported no remaining Allena Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 10,000 Allena Pharmaceuticals shares in Q1 2022, an estimated $6K.
  • PNC Financial Services Group first reported a position in Allena Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • PNC Financial Services Group's Allena Pharmaceuticals position peaked at $6K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q1 2022.

Based on PNC Financial Services Group's 13F filing for Q1 2022, filed 12 May 2022.